This topic contains a solution. Click here to go to the answer

Author Question: The risk of systemic toxicity from a surface anesthetic can be decreased by: a. spreading the ... (Read 60 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
The risk of systemic toxicity from a surface anesthetic can be decreased by:
 
  a. spreading the anesthetic over a large surface area to decrease concentration.
  b. applying the anesthetic to mucous membranes.
  c. avoiding abraded skin areas when applying the anesthetic.
  d. limiting the area of application to inflamed areas.

Question 2

While a woman is being treated for preterm labor with IV magnesium sulfate, it is essential that the nurse frequently assess the patient's:
 
  a. appetite.
  b. skin turgor.
  c. capillary refill.
  d. respirations.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ultraflyy23

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

c

Answer to Question 2

d




corkyiscool3328

  • Member
  • Posts: 539
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


chereeb

  • Member
  • Posts: 326
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

The modern decimal position system was the invention of the Hindus (around 800 AD), involving the placing of numerals to indicate their value (units, tens, hundreds, and so on).

Did you know?

The highest suicide rate in the United States is among people ages 65 years and older. Almost 15% of people in this age group commit suicide every year.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library